[In the Media] NCD Alliance Japan: How is COVID-19 affecting people living with NCDs?
date : 4/24/2020
Tags: NCDs
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus in 2019. With the spread of COVID-19 infections all over the world, the impact of COVID-19 on people living with non-communicable diseases (NCDs) including cancer, diabetes, cardiovascular diseases, chronic respiratory disease, mental health has been reported.
- The evidence from multiple countries at the epicentre of the pandemic clearly shows that people living with NCDs are more vulnerable to COVID-19. According to a study, the overall death rate from COVID-19 has been estimated at 0.66%, rising sharply to 7.8% in people aged over 80. *1
- Diabetes, cardiovascular disease, and chronic respiratory disease are the most common underlying diseases of hospitalized patients infected with COVID-19. It has also been pointed out that risk factors common to NCDs, such as smoking, are one of the factors that may aggravate COVID-19. World Health Organization warns that smokers likely face more severe symptoms if infected, leading to hospitalizations and premature deaths.
- Due to the limitation of daily life from self-quarantine and self-isolation, people living with NCDs are more likely to face difficulties with controlling their symptoms and taking medication as they may refrain from going to medical institutions because of fear of COVID-19 infection, and tend to have more stress than healthy people.
- NCDs involve many social determinants such as poverty and education. These social determinants of health are also obstacles to containment of COVID-19, and it is necessary to cultivate awareness and build a foundation for tackling it throughout society.
NCD Alliance Japan, a collaborative platform for civil society operated by Health Global Policy Institute, will do our best to raise our voices for the rights of people living with NCDs, older people and marginalised groups, and to collate and share information useful for COVID-19 infection prevention and control through a NCDs lens.
WHO: Information note on COVID-19 and NCDs (Published 23 March 2020)
https://www.who.int/who-documents-detail/covid-19-and-ncds
For more information about the NCD Alliance Japan, please visit us here:
https://ncdjapan.org/en/
*1: Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 2020 Mar 30
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30243-7/fulltext
Top Research & Recommendations Posts
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] HGPI Planetary Health Policy Team Joins Call for Global Fossil Fuel Non-proliferation Treaty (October 18, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-03-04
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Issues Surrounding and Necessary Measures Against Obesity Disease” (February 2, 2024)
-
2024-03-05
[HGPI Policy Column] (No.41) – From the Mental Health Project Team – Mental Health Policy in Japan – History and Future Policy Topics (Part 1 of HGPI Activities for Mental Health and Domestic Policy History)
-
2024-03-18
[Registration Open] International Symposium “Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (April 9, 2024)
-
2024-03-22
[Registration Open] (Hybrid Format) The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)
-
2024-03-26
[Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)